Nanjing Vishee Medical Technology Co., Ltd

Shanghai Stock Exchange 688580.SS

Nanjing Vishee Medical Technology Co., Ltd Free Cash Flow Per Share for the year ending December 31, 2023: USD 0.00

Nanjing Vishee Medical Technology Co., Ltd Free Cash Flow Per Share is USD 0.00 for the year ending December 31, 2023, a 107.38% change year over year. Free cash flow per share is the free cash flow generated per share. Indicates investment potential based on cash flow generation.

Nanjing Vishee Medical Technology Co., Ltd Free Cash Flow Per Share for the year ending December 31, 2022 was USD -0.01, a -112.46% change year over year.
Nanjing Vishee Medical Technology Co., Ltd Free Cash Flow Per Share for the year ending December 31, 2021 was USD 0.11, a -43.85% change year over year.
Nanjing Vishee Medical Technology Co., Ltd Free Cash Flow Per Share for the year ending December 31, 2020 was USD 0.20, a -15.00% change year over year.
Nanjing Vishee Medical Technology Co., Ltd Free Cash Flow Per Share for the year ending December 31, 2019 was USD 0.24, a 163.81% change year over year.

Key data

Date	Free Cash Flow Per Share	Return on Assets (ROA)	Return on Equity (ROE)	Return on Capital Employed (ROCE)

Shanghai Stock Exchange: 688580.SS

Nanjing Vishee Medical Technology Co., Ltd

CEO	Mr. Zhiyu Wang
IPO Date	July 21, 2020
Location	China
Headquarters	No. 19, Ningshuang Road
Employees	700
Sector	Technology
Industries 3D Printing Automotive Parts Biotechnology Hardware & Electronics Medical Instruments Musical Instruments Pharmaceuticals Robotics

Description

Nanjing Vishee Medical Technology Co., Ltd. develops and manufactures medical rehabilitation devices in China. It offers pelvic floor and postpartum, neurological, and mental rehabilitation solutions; and bio-stimulation feedback devices, magnetic stimulators, etc. The company's solutions cover markets, such as electrical and magnetic stimulation, electrophysiology, and other technical directions. It offers its products through dealers, sales network, and distributors to hospitals, and terminal medical and professional institutions. The company was founded in 2001 and is based in Nanjing, China.

Key trends

Past 5 years